<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-08-01" modified="2018-01-31" version="231">
<accession>P08631</accession>
<accession>A8K1I1</accession>
<accession>B4DQB6</accession>
<accession>E1P5M2</accession>
<accession>Q29RX1</accession>
<accession>Q2VPE2</accession>
<accession>Q504R5</accession>
<accession>Q5T7K1</accession>
<accession>Q5T7K2</accession>
<accession>Q96CC0</accession>
<accession>Q9H5Y5</accession>
<accession>Q9NUA4</accession>
<accession>Q9UMJ5</accession>
<name>HCK_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tyrosine-protein kinase HCK</fullName>
<ecNumber>2.7.10.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Hematopoietic cell kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Hemopoietic cell kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>p59-HCK/p60-HCK</fullName>
</alternativeName>
<alternativeName>
<fullName>p59Hck</fullName>
</alternativeName>
<alternativeName>
<fullName>p61Hck</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">HCK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="Mol. Cell. Biol." volume="7" first="2267" last="2275">
<title>Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells.</title>
<authorList>
<person name="Quintrell N."/>
<person name="Lebo R."/>
<person name="Varmus H."/>
<person name="Bishop J.M."/>
<person name="Pettenati M.J."/>
<person name="le Beau M.M."/>
<person name="Diaz M.O."/>
<person name="Rowley J.D."/>
</authorList>
<dbReference type="PubMed" id="3496523"/>
<dbReference type="DOI" id="10.1128/MCB.7.6.2267"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1987" name="Mol. Cell. Biol." volume="7" first="2276" last="2285">
<title>Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin.</title>
<authorList>
<person name="Ziegler S.F."/>
<person name="Marth J.D."/>
<person name="Lewis D.B."/>
<person name="Perlmutter R.M."/>
</authorList>
<dbReference type="PubMed" id="3453117"/>
<dbReference type="DOI" id="10.1128/MCB.7.6.2276"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4)</scope>
<scope>VARIANT LEU-105</scope>
<source>
<tissue>Corpus callosum</tissue>
<tissue>Ileal mucosa</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3)</scope>
<source>
<tissue>B-cell</tissue>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="4363" last="4370">
<title>Two isoforms of murine hck, generated by utilization of alternative translational initiation codons, exhibit different patterns of subcellular localization.</title>
<authorList>
<person name="Lock P."/>
<person name="Ralph S."/>
<person name="Stanley E."/>
<person name="Boulet I."/>
<person name="Ramsay R."/>
<person name="Dunn A.R."/>
</authorList>
<dbReference type="PubMed" id="1875927"/>
<dbReference type="DOI" id="10.1128/MCB.11.9.4363"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-21 (ISOFORM 1)</scope>
<scope>ALTERNATIVE INITIATION</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1992" name="Gene" volume="113" first="275" last="280">
<title>The genomic locus of the human hemopoietic-specific cell protein tyrosine kinase (PTK)-encoding gene (HCK) confirms conservation of exon-intron structure among human PTKs of the src family.</title>
<authorList>
<person name="Hradetzky D."/>
<person name="Strebhardt K."/>
<person name="Ruesamen-Waigmann H."/>
</authorList>
<dbReference type="PubMed" id="1572549"/>
<dbReference type="DOI" id="10.1016/0378-1119(92)90407-G"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 178-526</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="8878" last="8884">
<title>Physical and functional association of Src-related protein tyrosine kinases with Fc gamma RII in monocytic THP-1 cells.</title>
<authorList>
<person name="Ghazizadeh S."/>
<person name="Bolen J.B."/>
<person name="Fleit H.B."/>
</authorList>
<dbReference type="PubMed" id="8132624"/>
</citation>
<scope>INTERACTION WITH FCGR2A</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF FCGR2A</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1994" name="J. Exp. Med." volume="180" first="1165" last="1170">
<title>Physical and functional association of the high affinity immunoglobulin G receptor (Fc gamma RI) with the kinases Hck and Lyn.</title>
<authorList>
<person name="Wang A.V."/>
<person name="Scholl P.R."/>
<person name="Geha R.S."/>
</authorList>
<dbReference type="PubMed" id="8064233"/>
<dbReference type="DOI" id="10.1084/jem.180.3.1165"/>
</citation>
<scope>INTERACTION WITH FCGR1A</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1995" name="J. Immunol." volume="154" first="4039" last="4047">
<title>The Fc gamma RI receptor signals through the activation of hck and MAP kinase.</title>
<authorList>
<person name="Durden D.L."/>
<person name="Kim H.M."/>
<person name="Calore B."/>
<person name="Liu Y."/>
</authorList>
<dbReference type="PubMed" id="7535819"/>
</citation>
<scope>FUNCTION IN FCGR1A SIGNALING</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1995" name="Mol. Cell. Biol." volume="15" first="3507" last="3515">
<title>Myristoylation and differential palmitoylation of the HCK protein-tyrosine kinases govern their attachment to membranes and association with caveolae.</title>
<authorList>
<person name="Robbins S.M."/>
<person name="Quintrell N.A."/>
<person name="Bishop J.M."/>
</authorList>
<dbReference type="PubMed" id="7791757"/>
<dbReference type="DOI" id="10.1128/MCB.15.7.3507"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ALTERNATIVE INITIATION</scope>
<scope>MYRISTOYLATION AT GLY-2</scope>
<scope>MYRISTOYLATION AT GLY-2 (ISOFORM 2)</scope>
<scope>PALMITOYLATION AT CYS-3 (ISOFORM 2)</scope>
<scope>MUTAGENESIS OF GLY-3; GLY-23 AND CYS-24</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="Exp. Hematol." volume="25" first="1367" last="1377">
<title>Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines.</title>
<authorList>
<person name="Hallek M."/>
<person name="Neumann C."/>
<person name="Schaffer M."/>
<person name="Danhauser-Riedl S."/>
<person name="von Bubnoff N."/>
<person name="de Vos G."/>
<person name="Druker B.J."/>
<person name="Yasukawa K."/>
<person name="Griffin J.D."/>
<person name="Emmerich B."/>
</authorList>
<dbReference type="PubMed" id="9406996"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH IL6ST</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="102" last="109">
<title>Hck is activated by opsonized zymosan and A23187 in distinct subcellular fractions of human granulocytes.</title>
<authorList>
<person name="Welch H."/>
<person name="Maridonneau-Parini I."/>
</authorList>
<dbReference type="PubMed" id="8995234"/>
<dbReference type="DOI" id="10.1074/jbc.272.1.102"/>
</citation>
<scope>INDUCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="17899" last="17902">
<title>SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1.</title>
<authorList>
<person name="Briggs S.D."/>
<person name="Sharkey M."/>
<person name="Stevenson M."/>
<person name="Smithgall T.E."/>
</authorList>
<dbReference type="PubMed" id="9218412"/>
<dbReference type="DOI" id="10.1074/jbc.272.29.17899"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH HIV-1 NEF</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="33260" last="33270">
<title>The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr.</title>
<authorList>
<person name="Warmuth M."/>
<person name="Bergmann M."/>
<person name="Priess A."/>
<person name="Hauslmann K."/>
<person name="Emmerich B."/>
<person name="Hallek M."/>
</authorList>
<dbReference type="PubMed" id="9407116"/>
<dbReference type="DOI" id="10.1074/jbc.272.52.33260"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF BCR</scope>
<scope>INTERACTION WITH BCR-ABL</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="257" first="129" last="138">
<title>The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase.</title>
<authorList>
<person name="Howlett C.J."/>
<person name="Bisson S.A."/>
<person name="Resek M.E."/>
<person name="Tigley A.W."/>
<person name="Robbins S.M."/>
</authorList>
<dbReference type="PubMed" id="10092522"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0427"/>
</citation>
<scope>FUNCTION IN CBL PHOSPHORYLATION; CELL PROLIFERATION AND REGULATION OF CELL SHAPE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF TYR-522</scope>
<scope>INTERACTION WITH CBL</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="J. Immunol." volume="164" first="4575" last="4585">
<title>IL-2 signaling in human monocytes involves the phosphorylation and activation of p59hck.</title>
<authorList>
<person name="Bosco M.C."/>
<person name="Curiel R.E."/>
<person name="Zea A.H."/>
<person name="Malabarba M.G."/>
<person name="Ortaldo J.R."/>
<person name="Espinoza-Delgado I."/>
</authorList>
<dbReference type="PubMed" id="10779760"/>
<dbReference type="DOI" id="10.4049/jimmunol.164.9.4575"/>
</citation>
<scope>FUNCTION IN IL2 SIGNALING</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INDUCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="2721" last="2726">
<title>Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand.</title>
<authorList>
<person name="Porter M."/>
<person name="Schindler T."/>
<person name="Kuriyan J."/>
<person name="Miller W.T."/>
</authorList>
<dbReference type="PubMed" id="10644735"/>
<dbReference type="DOI" id="10.1074/jbc.275.4.2721"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-411 AND TYR-522</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF GLU-305 AND TYR-411</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Nat. Immunol." volume="1" first="227" last="233">
<title>Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI.</title>
<authorList>
<person name="Barlic J."/>
<person name="Andrews J.D."/>
<person name="Kelvin A.A."/>
<person name="Bosinger S.E."/>
<person name="DeVries M.E."/>
<person name="Xu L."/>
<person name="Dobransky T."/>
<person name="Feldman R.D."/>
<person name="Ferguson S.S."/>
<person name="Kelvin D.J."/>
</authorList>
<dbReference type="PubMed" id="10973280"/>
<dbReference type="DOI" id="10.1038/79767"/>
</citation>
<scope>FUNCTION IN IL8-MEDIATED DEGRANULATION</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH ARRB1 AND ARRB2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="16885" last="16893">
<title>The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein.</title>
<authorList>
<person name="Hassaine G."/>
<person name="Courcoul M."/>
<person name="Bessou G."/>
<person name="Barthalay Y."/>
<person name="Picard C."/>
<person name="Olive D."/>
<person name="Collette Y."/>
<person name="Vigne R."/>
<person name="Decroly E."/>
</authorList>
<dbReference type="PubMed" id="11278465"/>
<dbReference type="DOI" id="10.1074/jbc.M009076200"/>
</citation>
<scope>INTERACTION WITH HIV-1 VIF</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="42389" last="42400">
<title>The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK.</title>
<authorList>
<person name="Korkaya H."/>
<person name="Jameel S."/>
<person name="Gupta D."/>
<person name="Tyagi S."/>
<person name="Kumar R."/>
<person name="Zafrullah M."/>
<person name="Mazumdar M."/>
<person name="Lal S.K."/>
<person name="Xiaofang L."/>
<person name="Sehgal D."/>
<person name="Das S.R."/>
<person name="Sahal D."/>
</authorList>
<dbReference type="PubMed" id="11518702"/>
<dbReference type="DOI" id="10.1074/jbc.M101546200"/>
</citation>
<scope>INTERACTION WITH HEV ORF3 PROTEIN</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="5766" last="5774">
<title>The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.</title>
<authorList>
<person name="Klejman A."/>
<person name="Schreiner S.J."/>
<person name="Nieborowska-Skorska M."/>
<person name="Slupianek A."/>
<person name="Wilson M."/>
<person name="Smithgall T.E."/>
<person name="Skorski T."/>
</authorList>
<dbReference type="PubMed" id="12411494"/>
<dbReference type="DOI" id="10.1093/emboj/cdf562"/>
</citation>
<scope>FUNCTION AS EFFECTOR OF THE BCR-ABL FUSION PROTEIN IN PHOSPHORYLATION OF STAT5B</scope>
<scope>INTERACTION WITH STAT5B AND THE BCR-ABL FUSION PROTEIN</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="4999" last="5007">
<title>Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.</title>
<authorList>
<person name="Poghosyan Z."/>
<person name="Robbins S.M."/>
<person name="Houslay M.D."/>
<person name="Webster A."/>
<person name="Murphy G."/>
<person name="Edwards D.R."/>
</authorList>
<dbReference type="PubMed" id="11741929"/>
<dbReference type="DOI" id="10.1074/jbc.M107430200"/>
</citation>
<scope>INTERACTION WITH ADAM15</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF ADAM15</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="21007" last="21016">
<title>p59Hck isoform induces F-actin reorganization to form protrusions of the plasma membrane in a Cdc42- and Rac-dependent manner.</title>
<authorList>
<person name="Carreno S."/>
<person name="Caron E."/>
<person name="Cougoule C."/>
<person name="Emorine L.J."/>
<person name="Maridonneau-Parini I."/>
</authorList>
<dbReference type="PubMed" id="11904303"/>
<dbReference type="DOI" id="10.1074/jbc.M201212200"/>
</citation>
<scope>FUNCTION IN REORGANIZATION OF THE ACTIN CYTOSKELETON; FORMATION OF CELL PROTRUSIONS AND PHAGOCYTOSIS (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 2)</scope>
<scope>MUTAGENESIS OF GLY-3</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="1707" last="1716">
<title>Membrane-anchored Cbl suppresses Hck protein-tyrosine kinase mediated cellular transformation.</title>
<authorList>
<person name="Howlett C.J."/>
<person name="Robbins S.M."/>
</authorList>
<dbReference type="PubMed" id="11896602"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205228"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
<scope>UBIQUITINATION</scope>
<scope>PHOSPHORYLATION AT TYR-51; TYR-411 AND TYR-522</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CBL (ISOFORM 2)</scope>
<scope>MUTAGENESIS OF LYS-290 AND TYR-522</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="21658" last="21665">
<title>Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells.</title>
<authorList>
<person name="Podar K."/>
<person name="Mostoslavsky G."/>
<person name="Sattler M."/>
<person name="Tai Y.T."/>
<person name="Hayashi T."/>
<person name="Catley L.P."/>
<person name="Hideshima T."/>
<person name="Mulligan R.C."/>
<person name="Chauhan D."/>
<person name="Anderson K.C."/>
</authorList>
<dbReference type="PubMed" id="15010462"/>
<dbReference type="DOI" id="10.1074/jbc.M305783200"/>
</citation>
<scope>FUNCTION IN IL6 SIGNALING CASCADE AND IN PHOSPHORYLATION OF GAB1 AND GAB2</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2005" name="Biochemistry" volume="44" first="8841" last="8849">
<title>Identification of tyrosine residues on ELMO1 that are phosphorylated by the Src-family kinase Hck.</title>
<authorList>
<person name="Yokoyama N."/>
<person name="deBakker C.D."/>
<person name="Zappacosta F."/>
<person name="Huddleston M.J."/>
<person name="Annan R.S."/>
<person name="Ravichandran K.S."/>
<person name="Miller W.T."/>
</authorList>
<dbReference type="PubMed" id="15952790"/>
<dbReference type="DOI" id="10.1021/bi0500832"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF ELMO1</scope>
<scope>INTERACTION WITH ELMO1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="Traffic" volume="6" first="682" last="694">
<title>Activation of the lysosome-associated p61Hck isoform triggers the biogenesis of podosomes.</title>
<authorList>
<person name="Cougoule C."/>
<person name="Carreno S."/>
<person name="Castandet J."/>
<person name="Labrousse A."/>
<person name="Astarie-Dequeker C."/>
<person name="Poincloux R."/>
<person name="Le Cabec V."/>
<person name="Maridonneau-Parini I."/>
</authorList>
<dbReference type="PubMed" id="15998323"/>
<dbReference type="DOI" id="10.1111/j.1600-0854.2005.00307.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASP-381</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="27029" last="27038">
<title>HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.</title>
<authorList>
<person name="Trible R.P."/>
<person name="Emert-Sedlak L."/>
<person name="Smithgall T.E."/>
</authorList>
<dbReference type="PubMed" id="16849330"/>
<dbReference type="DOI" id="10.1074/jbc.M601128200"/>
</citation>
<scope>INTERACTION WITH HIV-1 NEF</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="BMC Mol. Biol." volume="8" first="45" last="45">
<title>Regulation of p73 by Hck through kinase-dependent and independent mechanisms.</title>
<authorList>
<person name="Paliwal P."/>
<person name="Radha V."/>
<person name="Swarup G."/>
</authorList>
<dbReference type="PubMed" id="17535448"/>
<dbReference type="DOI" id="10.1186/1471-2199-8-45"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION AND INHIBITION OF TP73 ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH TP73 AND YAP1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="4987" last="4998">
<title>Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases.</title>
<authorList>
<person name="Hausherr A."/>
<person name="Tavares R."/>
<person name="Schaffer M."/>
<person name="Obermeier A."/>
<person name="Miksch C."/>
<person name="Mitina O."/>
<person name="Ellwart J."/>
<person name="Hallek M."/>
<person name="Krause G."/>
</authorList>
<dbReference type="PubMed" id="17310994"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210306"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IL6ST</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="BMC Immunol." volume="10" first="53" last="53">
<title>Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.</title>
<authorList>
<person name="Voss M."/>
<person name="Lettau M."/>
<person name="Janssen O."/>
</authorList>
<dbReference type="PubMed" id="19807924"/>
<dbReference type="DOI" id="10.1186/1471-2172-10-53"/>
</citation>
<scope>INTERACTION WITH FASLG</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Eur. J. Cancer" volume="45" first="321" last="327">
<title>The oncogenic activity of the Src family kinase Hck requires the cooperative action of the plasma membrane- and lysosome-associated isoforms.</title>
<authorList>
<person name="Poincloux R."/>
<person name="Al Saati T."/>
<person name="Maridonneau-Parini I."/>
<person name="Le Cabec V."/>
</authorList>
<dbReference type="PubMed" id="19114024"/>
<dbReference type="DOI" id="10.1016/j.ejca.2008.11.020"/>
</citation>
<scope>FUNCTION IN REORGANIZATION OF ACTIN CYTOSKELETON AND CELL PROLIFERATION</scope>
<scope>ROLE IN DISEASE</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="J. Cell. Biochem." volume="108" first="877" last="885">
<title>Alternative splicing of ADAM15 regulates its interactions with cellular SH3 proteins.</title>
<authorList>
<person name="Kleino I."/>
<person name="Ortiz R.M."/>
<person name="Yritys M."/>
<person name="Huovila A.P."/>
<person name="Saksela K."/>
</authorList>
<dbReference type="PubMed" id="19718658"/>
<dbReference type="DOI" id="10.1002/jcb.22317"/>
</citation>
<scope>INTERACTION WITH ADAM15</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-202 AND SER-462</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="FEBS Lett." volume="584" first="15" last="21">
<title>c-Abl and Src-family kinases cross-talk in regulation of myeloid cell migration.</title>
<authorList>
<person name="Baruzzi A."/>
<person name="Iacobucci I."/>
<person name="Soverini S."/>
<person name="Lowell C.A."/>
<person name="Martinelli G."/>
<person name="Berton G."/>
</authorList>
<dbReference type="PubMed" id="19903482"/>
<dbReference type="DOI" id="10.1016/j.febslet.2009.11.009"/>
</citation>
<scope>FUNCTION IN ABL1-MEDIATED CELL MIGRATION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH ITGB1 AND WITH ABL1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="21446" last="21457">
<title>Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner.</title>
<authorList>
<person name="Pene-Dumitrescu T."/>
<person name="Smithgall T.E."/>
</authorList>
<dbReference type="PubMed" id="20452982"/>
<dbReference type="DOI" id="10.1074/jbc.M109.090043"/>
</citation>
<scope>ROLE IN DISEASE</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF THE BCR-ABL FUSION PROTEIN</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="Eur. J. Cell Biol." volume="87" first="527" last="542">
<title>Hematopoietic cell kinase (Hck) isoforms and phagocyte duties - from signaling and actin reorganization to migration and phagocytosis.</title>
<authorList>
<person name="Guiet R."/>
<person name="Poincloux R."/>
<person name="Castandet J."/>
<person name="Marois L."/>
<person name="Labrousse A."/>
<person name="Le Cabec V."/>
<person name="Maridonneau-Parini I."/>
</authorList>
<dbReference type="PubMed" id="18538446"/>
<dbReference type="DOI" id="10.1016/j.ejcb.2008.03.008"/>
</citation>
<scope>REVIEW ON ROLE IN PHAGOCYTOSIS AND SUBSTRATES</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="Arch. Biochem. Biophys." volume="510" first="112" last="119">
<title>Protein tyrosine kinases in neutrophil activation and recruitment.</title>
<authorList>
<person name="Zarbock A."/>
<person name="Ley K."/>
</authorList>
<dbReference type="PubMed" id="21338576"/>
<dbReference type="DOI" id="10.1016/j.abb.2011.02.009"/>
</citation>
<scope>ROLE IN NEUTROPHIL FUNCTION</scope>
<scope>SIGNALING</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-36</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2015" name="Biomed. Rep." volume="3" first="9" last="13">
<title>Molecular characterization of WDCP, a novel fusion partner for the anaplastic lymphoma tyrosine kinase ALK.</title>
<authorList>
<person name="Yokoyama N."/>
<person name="Miller W.T."/>
</authorList>
<dbReference type="PubMed" id="25469238"/>
<dbReference type="DOI" id="10.3892/br.2014.374"/>
</citation>
<scope>INTERACTION WITH WDCP</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1997" name="FEBS Lett." volume="406" first="131" last="135">
<title>Sequential assignment and secondary structure determination for the Src homology 2 domain of hematopoietic cellular kinase.</title>
<authorList>
<person name="Zhang W."/>
<person name="Smithgall T.E."/>
<person name="Gmeiner W.H."/>
</authorList>
<dbReference type="PubMed" id="9109402"/>
<dbReference type="DOI" id="10.1016/S0014-5793(97)00255-X"/>
</citation>
<scope>STRUCTURE BY NMR OF 140-245</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1997" name="Nature" volume="385" first="602" last="609">
<title>Crystal structure of the Src family tyrosine kinase Hck.</title>
<authorList>
<person name="Sicheri F."/>
<person name="Moarefi I."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="9024658"/>
<dbReference type="DOI" id="10.1038/385602a0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 78-526 IN COMPLEX WITH CALCIUM</scope>
<scope>PHOSPHORYLATION AT TYR-522</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1998" name="Biochemistry" volume="37" first="14683" last="14691">
<title>RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.</title>
<authorList>
<person name="Arold S."/>
<person name="O'Brien R."/>
<person name="Franken P."/>
<person name="Strub M.-P."/>
<person name="Hoh F."/>
<person name="Dumas C."/>
<person name="Ladbury J.E."/>
</authorList>
<dbReference type="PubMed" id="9778343"/>
<dbReference type="DOI" id="10.1021/bi980989q"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 81-137</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1998" name="J. Mol. Biol." volume="278" first="253" last="265">
<title>Solution structure of the human Hck SH3 domain and identification of its ligand binding site.</title>
<authorList>
<person name="Horita D.A."/>
<person name="Baldisseri D.M."/>
<person name="Zhang W."/>
<person name="Altieri A.S."/>
<person name="Smithgall T.E."/>
<person name="Gmeiner W.H."/>
<person name="Byrd R.A."/>
</authorList>
<dbReference type="PubMed" id="9571048"/>
<dbReference type="DOI" id="10.1006/jmbi.1998.1690"/>
</citation>
<scope>STRUCTURE BY NMR OF 72-143</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1999" name="Mol. Cell" volume="3" first="639" last="648">
<title>Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor.</title>
<authorList>
<person name="Schindler T."/>
<person name="Sicheri F."/>
<person name="Pico A."/>
<person name="Gazit A."/>
<person name="Levitzki A."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="10360180"/>
<dbReference type="DOI" id="10.1016/S1097-2765(00)80357-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 81-522 IN COMPLEX WITH THE PYRAZOLO PYRIMIDINE-TYPE INHIBITOR PP1</scope>
<scope>PHOSPHORYLATION AT TYR-522</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2006" name="Bioorg. Med. Chem. Lett." volume="16" first="118" last="122">
<title>Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection.</title>
<authorList>
<person name="Burchat A."/>
<person name="Borhani D.W."/>
<person name="Calderwood D.J."/>
<person name="Hirst G.C."/>
<person name="Li B."/>
<person name="Stachlewitz R.F."/>
</authorList>
<dbReference type="PubMed" id="16216497"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2005.09.039"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 81-522 IN COMPLEXES WITH INHIBITORS A-420983; A-641359 AND A-770041</scope>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION AT TYR-522</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2006" name="Bioorg. Med. Chem. Lett." volume="16" first="5973" last="5977">
<title>The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck).</title>
<authorList>
<person name="Sabat M."/>
<person name="VanRens J.C."/>
<person name="Laufersweiler M.J."/>
<person name="Brugel T.A."/>
<person name="Maier J."/>
<person name="Golebiowski A."/>
<person name="De B."/>
<person name="Easwaran V."/>
<person name="Hsieh L.C."/>
<person name="Walter R.L."/>
<person name="Mekel M.J."/>
<person name="Evdokimov A."/>
<person name="Janusz M.J."/>
</authorList>
<dbReference type="PubMed" id="16997556"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2006.08.132"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 247-513 IN COMPLEX WITH INHIBITOR PG-1009247</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="365" first="1517" last="1532">
<title>Solution structure of a Hck SH3 domain ligand complex reveals novel interaction modes.</title>
<authorList>
<person name="Schmidt H."/>
<person name="Hoffmann S."/>
<person name="Tran T."/>
<person name="Stoldt M."/>
<person name="Stangler T."/>
<person name="Wiesehan K."/>
<person name="Willbold D."/>
</authorList>
<dbReference type="PubMed" id="17141806"/>
<dbReference type="DOI" id="10.1016/j.jmb.2006.11.013"/>
</citation>
<scope>STRUCTURE BY NMR OF 61-140 IN COMPLEX WITH PROLINE-RICH SYNTHETIC PEPTIDE</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="35455" last="35461">
<title>Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.</title>
<authorList>
<person name="Alvarado J.J."/>
<person name="Betts L."/>
<person name="Moroco J.A."/>
<person name="Smithgall T.E."/>
<person name="Yeh J.I."/>
</authorList>
<dbReference type="PubMed" id="20810664"/>
<dbReference type="DOI" id="10.1074/jbc.M110.145102"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.61 ANGSTROMS) OF 72-256</scope>
<scope>ENZYME REGULATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E20033" last="E20033">
<title>Molecular design, functional characterization and structural basis of a protein inhibitor against the HIV-1 pathogenicity factor Nef.</title>
<authorList>
<person name="Breuer S."/>
<person name="Schievink S.I."/>
<person name="Schulte A."/>
<person name="Blankenfeldt W."/>
<person name="Fackler O.T."/>
<person name="Geyer M."/>
</authorList>
<dbReference type="PubMed" id="21625496"/>
<dbReference type="DOI" id="10.1371/journal.pone.0020033"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.45 ANGSTROMS) OF 79-138 IN COMPLEX WITH HIV-1 NEF</scope>
<scope>INTERACTION WITH HIV-1 NEF</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2011" name="Traffic" volume="12" first="867" last="877">
<title>Conformation of the dileucine-based sorting motif in HIV-1 Nef revealed by intermolecular domain assembly.</title>
<authorList>
<person name="Horenkamp F.A."/>
<person name="Breuer S."/>
<person name="Schulte A."/>
<person name="Lulf S."/>
<person name="Weyand M."/>
<person name="Saksela K."/>
<person name="Geyer M."/>
</authorList>
<dbReference type="PubMed" id="21477083"/>
<dbReference type="DOI" id="10.1111/j.1600-0854.2011.01205.x"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 79-138 IN COMPLEX WITH HIV-1 NEF</scope>
<scope>INTERACTION WITH HIV-1 NEF</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] THR-44; LEU-105 AND GLY-399</scope>
</reference>
<comment type="function">
<text evidence="20 23 24 27 28 30 32 33 34 39 41 42 45 46 48 53 56 60 61">Non-receptor tyrosine-protein kinase found in hematopoietic cells that transmits signals from cell surface receptors and plays an important role in the regulation of innate immune responses, including neutrophil, monocyte, macrophage and mast cell functions, phagocytosis, cell survival and proliferation, cell adhesion and migration. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as FCGR1A and FCGR2A, but also CSF3R, PLAUR, the receptors for IFNG, IL2, IL6 and IL8, and integrins, such as ITGB1 and ITGB2. During the phagocytic process, mediates mobilization of secretory lysosomes, degranulation, and activation of NADPH oxidase to bring about the respiratory burst. Plays a role in the release of inflammatory molecules. Promotes reorganization of the actin cytoskeleton and actin polymerization, formation of podosomes and cell protrusions. Inhibits TP73-mediated transcription activation and TP73-mediated apoptosis. Phosphorylates CBL in response to activation of immunoglobulin gamma Fc region receptors. Phosphorylates ADAM15, BCR, ELMO1, FCGR2A, GAB1, GAB2, RAPGEF1, STAT5B, TP73, VAV1 and WAS.</text>
</comment>
<comment type="catalytic activity">
<text evidence="19 20 23 34 47 53 55 56 57">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="22 23 24 35 36 47 53 59 60">Subject to autoinhibition, mediated by intramolecular interactions involving the SH2 and SH3 domains. Kinase activity is also regulated by phosphorylation at regulatory tyrosine residues. Phosphorylation at Tyr-411 is required for optimal activity. Phosphorylation at Tyr-522 inhibits kinase activity. Inhibited by PP1 and A-770041.</text>
</comment>
<comment type="subunit">
<text evidence="14 20 21 24 25 26 27 30 33 36 37 38 39 41 43 44 45 49 50 51 55 56 58 59 60 61">Interacts (via SH2 domain) with FLT3 (tyrosine phosphorylated). Interacts with VAV1, WAS and RAPGEF1 (By similarity). Interacts (via SH3 domain) with HIV-1 Nef and Vif. This interaction stimulates its tyrosine-kinase activity. Interacts (via SH3 domain) with HEV ORF3 protein. Interacts with ARRB1 and ARRB2. Interacts with ADAM15. Interacts with FASLG. Interacts with CBL. Interacts with FCGR1A; the interaction may be indirect. Interacts with IL6ST. Interacts (via SH3 domain) with ELMO1. Interacts (via SH3 domain) with TP73. Interacts with YAP1. Interacts with ABL1 and ITGB1, and thereby recruits ABL1 to activated ITGB1. Interacts (via SH3 domain) with WDCP.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-710506">
<id>O92972</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-706378">
<id>P27958</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-77818">
<id>Q13444</id>
<label>ADAM15</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-79934">
<id>P09917</id>
<label>ALOX5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-346622">
<id>Q9ULH1</id>
<label>ASAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9834454"/>
<interactant intactId="EBI-518228">
<id>P22681</id>
<label>CBL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-346417">
<id>Q92556</id>
<label>ELMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-720706">
<id>P21860</id>
<label>ERBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-1026718">
<id>P17948</id>
<label>FLT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9834454"/>
<interactant intactId="EBI-725515">
<id>O43559</id>
<label>FRS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-349832">
<id>Q9HD26</id>
<label>GOPC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-1364">
<id>Q07666</id>
<label>KHDRBS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-10171697">
<id>Q6A162</id>
<label>KRT40</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-10172052">
<id>P60411</id>
<label>KRTAP10-9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-742948">
<id>Q5JR59</id>
<label>MTUS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-15672419">
<id>P03406</id>
<label>nef</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-7460704">
<id>Q90VU7</id>
<label>nef</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-945833">
<id>Q7Z3S9</id>
<label>NOTCH2NL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9834454"/>
<interactant intactId="EBI-3867416">
<id>Q8TAK6</id>
<label>OLIG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-1045887">
<id>Q13177</id>
<label>PAK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-310624">
<id>Q8WUM4</id>
<label>PDCD6IP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-2609540">
<id>P42338</id>
<label>PIK3CB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9834454"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9834454"/>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-297487">
<id>Q07889</id>
<label>SOS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-779991">
<id>P12504</id>
<label>vif</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-346375">
<id>P42768</id>
<label>WAS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346340"/>
<interactant intactId="EBI-346356">
<id>O43516</id>
<label>WIPF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Lysosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Membrane</location>
<topology>Lipid-anchor</topology>
</subcellularLocation>
<subcellularLocation>
<location>Cell projection</location>
<location>podosome membrane</location>
<topology>Lipid-anchor</topology>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>cytosol</location>
</subcellularLocation>
<text>Associated with specialized secretory lysosomes called azurophil granules. At least half of this isoform is found in the cytoplasm, some of this fraction is myristoylated.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="29">Cell membrane</location>
<topology evidence="29">Lipid-anchor</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="29">Membrane</location>
<location evidence="29">caveola</location>
<topology evidence="29">Lipid-anchor</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="29">Cell junction</location>
<location evidence="29">focal adhesion</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="29">Cytoplasm</location>
<location evidence="29">cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="29">Golgi apparatus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="29">Cytoplasmic vesicle</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="29">Lysosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="29">Nucleus</location>
</subcellularLocation>
<text>20% of this isoform is associated with caveolae. Localization at the cell membrane and at caveolae requires palmitoylation at Cys-3. Colocalizes with the actin cytoskeleton at focal adhesions.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasmic vesicle</location>
<location>secretory vesicle</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>cytosol</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>P08631-1</id>
<name>1</name>
<name>p60-HCK</name>
<name>p61Hck</name>
<sequence type="displayed"/>
<text>Initiates from a CTG codon.</text>
</isoform>
<isoform>
<id>P08631-2</id>
<name>2</name>
<name>p59-HCK</name>
<name>p59Hck</name>
<sequence type="described" ref="VSP_018858"/>
<text evidence="54">Initiator Met-1 is removed. Contains a N-myristoyl glycine at position 2. Contains a S-palmitoyl cysteine at position 3.</text>
</isoform>
<isoform>
<id>P08631-3</id>
<name>3</name>
<sequence type="described" ref="VSP_018858 VSP_041926"/>
</isoform>
<isoform>
<id>P08631-4</id>
<name>4</name>
<sequence type="described" ref="VSP_041926"/>
<text>Initiates from a CTG codon.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="52 55 57">Detected in monocytes and neutrophils (at protein level). Expressed predominantly in cells of the myeloid and B-lymphoid lineages. Highly expressed in granulocytes. Detected in tonsil.</text>
</comment>
<comment type="induction">
<text evidence="23 57">Up-regulated during myeloid cell differentiation. The highest levels are detected in fully differentiated phagocytes. Up-regulated by IL2.</text>
</comment>
<comment type="domain">
<text>The SH3 domain mediates binding to HIV-1 Nef.</text>
</comment>
<comment type="PTM">
<text evidence="21 22 23 28 30 35 55 58 60">Phosphorylated on several tyrosine residues. Autophosphorylated. Becomes rapidly phosphorylated upon activation of the immunoglobulin receptors FCGR1A and FCGR2A. Phosphorylation by the BCR-ABL fusion protein mediates activation of HCK. Phosphorylation at Tyr-411 increases kinase activity. Phosphorylation at Tyr-522 inhibits kinase activity. Kinase activity is not required for phosphorylation at Tyr-522, suggesting that this site is a target of other kinases.</text>
</comment>
<comment type="PTM">
<text evidence="28">Ubiquitinated by CBL, leading to its degradation via the proteasome.</text>
</comment>
<comment type="PTM">
<text evidence="54">Isoform 2 palmitoylation at position 2 requires prior myristoylation. Palmitoylation at position 3 is required for caveolar localization of isoform 2.</text>
</comment>
<comment type="disease">
<text>Aberrant activation of HCK by HIV-1 protein Nef enhances HIV-1 replication and contributes to HIV-1 pathogenicity.</text>
</comment>
<comment type="disease">
<text>Aberrant activation of HCK, e.g. by the BCR-ABL fusion protein, promotes cancer cell proliferation.</text>
</comment>
<comment type="similarity">
<text evidence="16">Belongs to the protein kinase superfamily. Tyr protein kinase family. SRC subfamily.</text>
</comment>
<comment type="sequence caution" evidence="65">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAA52643" version="1"/>
</conflict>
<location>
<position position="20"/>
</location>
</comment>
<comment type="sequence caution" evidence="65">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAF82585" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="M16591">
<property type="protein sequence ID" value="AAA52643.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M16592">
<property type="protein sequence ID" value="AAA52644.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK026432">
<property type="protein sequence ID" value="BAB15482.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK289896">
<property type="protein sequence ID" value="BAF82585.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK298726">
<property type="protein sequence ID" value="BAG60878.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353092">
<property type="protein sequence ID" value="CAI19694.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049539">
<property type="protein sequence ID" value="CAI19694.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353092">
<property type="protein sequence ID" value="CAI19695.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049539">
<property type="protein sequence ID" value="CAI19695.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049539">
<property type="protein sequence ID" value="CAI22966.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353092">
<property type="protein sequence ID" value="CAI22966.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL049539">
<property type="protein sequence ID" value="CAI22967.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353092">
<property type="protein sequence ID" value="CAI22967.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW76392.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW76393.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014435">
<property type="protein sequence ID" value="AAH14435.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC094847">
<property type="protein sequence ID" value="AAH94847.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC108930">
<property type="protein sequence ID" value="AAI08931.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC108931">
<property type="protein sequence ID" value="AAI08932.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113854">
<property type="protein sequence ID" value="AAI13855.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC114463">
<property type="protein sequence ID" value="AAI14464.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X58741">
<property type="protein sequence ID" value="CAA41565.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X58742">
<property type="protein sequence ID" value="CAA41565.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X58743">
<property type="protein sequence ID" value="CAA41565.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33460.1">
<molecule id="P08631-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54453.1">
<molecule id="P08631-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54455.1">
<molecule id="P08631-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54456.1">
<molecule id="P08631-3"/>
</dbReference>
<dbReference type="PIR" id="A27811">
<property type="entry name" value="TVHUHC"/>
</dbReference>
<dbReference type="PIR" id="A41263">
<property type="entry name" value="A41263"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001165600.1">
<molecule id="P08631-2"/>
<property type="nucleotide sequence ID" value="NM_001172129.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001165601.1">
<molecule id="P08631-4"/>
<property type="nucleotide sequence ID" value="NM_001172130.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001165602.1">
<molecule id="P08631-3"/>
<property type="nucleotide sequence ID" value="NM_001172131.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001165604.1">
<molecule id="P08631-2"/>
<property type="nucleotide sequence ID" value="NM_001172133.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002101.2">
<molecule id="P08631-1"/>
<property type="nucleotide sequence ID" value="NM_002110.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.655210"/>
<dbReference type="PDB" id="1AD5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=79-526"/>
</dbReference>
<dbReference type="PDB" id="1BU1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D/E/F=81-137"/>
</dbReference>
<dbReference type="PDB" id="1QCF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=81-526"/>
</dbReference>
<dbReference type="PDB" id="2C0I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="2C0O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="2C0T">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="2HCK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=79-526"/>
</dbReference>
<dbReference type="PDB" id="2HK5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=247-514"/>
</dbReference>
<dbReference type="PDB" id="2OI3">
<property type="method" value="NMR"/>
<property type="chains" value="A=61-141"/>
</dbReference>
<dbReference type="PDB" id="2OJ2">
<property type="method" value="NMR"/>
<property type="chains" value="A=61-141"/>
</dbReference>
<dbReference type="PDB" id="3HCK">
<property type="method" value="NMR"/>
<property type="chains" value="A=140-245"/>
</dbReference>
<dbReference type="PDB" id="3NHN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.61"/>
<property type="chains" value="A=72-256"/>
</dbReference>
<dbReference type="PDB" id="3RBB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="B/D=79-138"/>
</dbReference>
<dbReference type="PDB" id="3REA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B/D=79-138"/>
</dbReference>
<dbReference type="PDB" id="3REB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.45"/>
<property type="chains" value="B/D=79-138"/>
</dbReference>
<dbReference type="PDB" id="3VRY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="3VRZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.22"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="3VS0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.93"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="3VS1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.46"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="3VS2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.61"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="3VS3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.17"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="3VS4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="3VS5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="3VS6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="3VS7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="4HCK">
<property type="method" value="NMR"/>
<property type="chains" value="A=72-143"/>
</dbReference>
<dbReference type="PDB" id="4LUD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="4LUE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.04"/>
<property type="chains" value="A/B=81-526"/>
</dbReference>
<dbReference type="PDB" id="4ORZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=77-138"/>
</dbReference>
<dbReference type="PDB" id="4U5W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.86"/>
<property type="chains" value="B/D=72-242"/>
</dbReference>
<dbReference type="PDB" id="5H09">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=81-526"/>
</dbReference>
<dbReference type="PDB" id="5H0B">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=81-526"/>
</dbReference>
<dbReference type="PDB" id="5H0E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=81-526"/>
</dbReference>
<dbReference type="PDB" id="5H0G">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=81-526"/>
</dbReference>
<dbReference type="PDB" id="5H0H">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.72"/>
<property type="chains" value="A=81-526"/>
</dbReference>
<dbReference type="PDB" id="5HCK">
<property type="method" value="NMR"/>
<property type="chains" value="A=72-143"/>
</dbReference>
<dbReference type="PDB" id="5NUH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.78"/>
<property type="chains" value="C/D=79-138"/>
</dbReference>
<dbReference type="PDBsum" id="1AD5"/>
<dbReference type="PDBsum" id="1BU1"/>
<dbReference type="PDBsum" id="1QCF"/>
<dbReference type="PDBsum" id="2C0I"/>
<dbReference type="PDBsum" id="2C0O"/>
<dbReference type="PDBsum" id="2C0T"/>
<dbReference type="PDBsum" id="2HCK"/>
<dbReference type="PDBsum" id="2HK5"/>
<dbReference type="PDBsum" id="2OI3"/>
<dbReference type="PDBsum" id="2OJ2"/>
<dbReference type="PDBsum" id="3HCK"/>
<dbReference type="PDBsum" id="3NHN"/>
<dbReference type="PDBsum" id="3RBB"/>
<dbReference type="PDBsum" id="3REA"/>
<dbReference type="PDBsum" id="3REB"/>
<dbReference type="PDBsum" id="3VRY"/>
<dbReference type="PDBsum" id="3VRZ"/>
<dbReference type="PDBsum" id="3VS0"/>
<dbReference type="PDBsum" id="3VS1"/>
<dbReference type="PDBsum" id="3VS2"/>
<dbReference type="PDBsum" id="3VS3"/>
<dbReference type="PDBsum" id="3VS4"/>
<dbReference type="PDBsum" id="3VS5"/>
<dbReference type="PDBsum" id="3VS6"/>
<dbReference type="PDBsum" id="3VS7"/>
<dbReference type="PDBsum" id="4HCK"/>
<dbReference type="PDBsum" id="4LUD"/>
<dbReference type="PDBsum" id="4LUE"/>
<dbReference type="PDBsum" id="4ORZ"/>
<dbReference type="PDBsum" id="4U5W"/>
<dbReference type="PDBsum" id="5H09"/>
<dbReference type="PDBsum" id="5H0B"/>
<dbReference type="PDBsum" id="5H0E"/>
<dbReference type="PDBsum" id="5H0G"/>
<dbReference type="PDBsum" id="5H0H"/>
<dbReference type="PDBsum" id="5HCK"/>
<dbReference type="PDBsum" id="5NUH"/>
<dbReference type="ProteinModelPortal" id="P08631"/>
<dbReference type="SMR" id="P08631"/>
<dbReference type="BioGrid" id="109305">
<property type="interactions" value="63"/>
</dbReference>
<dbReference type="DIP" id="DIP-1051N"/>
<dbReference type="ELM" id="P08631"/>
<dbReference type="IntAct" id="P08631">
<property type="interactions" value="99"/>
</dbReference>
<dbReference type="MINT" id="MINT-135300"/>
<dbReference type="STRING" id="9606.ENSP00000365012"/>
<dbReference type="BindingDB" id="P08631"/>
<dbReference type="ChEMBL" id="CHEMBL3234"/>
<dbReference type="DrugBank" id="DB06616">
<property type="generic name" value="Bosutinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01962">
<property type="generic name" value="Phosphonotyrosine"/>
</dbReference>
<dbReference type="DrugBank" id="DB04216">
<property type="generic name" value="Quercetin"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2032"/>
<dbReference type="iPTMnet" id="P08631"/>
<dbReference type="PhosphoSitePlus" id="P08631"/>
<dbReference type="SwissPalm" id="P08631"/>
<dbReference type="BioMuta" id="HCK"/>
<dbReference type="DMDM" id="20141296"/>
<dbReference type="MaxQB" id="P08631"/>
<dbReference type="PaxDb" id="P08631"/>
<dbReference type="PeptideAtlas" id="P08631"/>
<dbReference type="PRIDE" id="P08631"/>
<dbReference type="DNASU" id="3055"/>
<dbReference type="Ensembl" id="ENST00000518730">
<molecule id="P08631-3"/>
<property type="protein sequence ID" value="ENSP00000427757"/>
<property type="gene ID" value="ENSG00000101336"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000520553">
<molecule id="P08631-2"/>
<property type="protein sequence ID" value="ENSP00000429848"/>
<property type="gene ID" value="ENSG00000101336"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000534862">
<molecule id="P08631-1"/>
<property type="protein sequence ID" value="ENSP00000444986"/>
<property type="gene ID" value="ENSG00000101336"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000538448">
<molecule id="P08631-2"/>
<property type="protein sequence ID" value="ENSP00000441169"/>
<property type="gene ID" value="ENSG00000101336"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000629881">
<molecule id="P08631-2"/>
<property type="protein sequence ID" value="ENSP00000486627"/>
<property type="gene ID" value="ENSG00000101336"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000639405">
<molecule id="P08631-4"/>
<property type="protein sequence ID" value="ENSP00000491964"/>
<property type="gene ID" value="ENSG00000101336"/>
</dbReference>
<dbReference type="GeneID" id="3055"/>
<dbReference type="KEGG" id="hsa:3055"/>
<dbReference type="UCSC" id="uc002wxi.4">
<molecule id="P08631-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3055"/>
<dbReference type="DisGeNET" id="3055"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000101336.12"/>
<dbReference type="GeneCards" id="HCK"/>
<dbReference type="HGNC" id="HGNC:4840">
<property type="gene designation" value="HCK"/>
</dbReference>
<dbReference type="HPA" id="CAB005195"/>
<dbReference type="HPA" id="HPA063768"/>
<dbReference type="MIM" id="142370">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P08631"/>
<dbReference type="OpenTargets" id="ENSG00000101336"/>
<dbReference type="PharmGKB" id="PA29216"/>
<dbReference type="eggNOG" id="KOG0197">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118938"/>
<dbReference type="HOGENOM" id="HOG000233858"/>
<dbReference type="HOVERGEN" id="HBG008761"/>
<dbReference type="InParanoid" id="P08631"/>
<dbReference type="KO" id="K08893"/>
<dbReference type="PhylomeDB" id="P08631"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-164944">
<property type="pathway name" value="Nef and signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029481">
<property type="pathway name" value="FCGR activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912631">
<property type="pathway name" value="Regulation of signaling by CBL"/>
</dbReference>
<dbReference type="SignaLink" id="P08631"/>
<dbReference type="SIGNOR" id="P08631"/>
<dbReference type="ChiTaRS" id="HCK">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P08631"/>
<dbReference type="GeneWiki" id="HCK"/>
<dbReference type="GenomeRNAi" id="3055"/>
<dbReference type="PRO" id="PR:P08631"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000101336"/>
<dbReference type="ExpressionAtlas" id="P08631">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P08631">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005901">
<property type="term" value="C:caveola"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042995">
<property type="term" value="C:cell projection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005856">
<property type="term" value="C:cytoskeleton"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031234">
<property type="term" value="C:extrinsic component of cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005764">
<property type="term" value="C:lysosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0030133">
<property type="term" value="C:transport vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001784">
<property type="term" value="F:phosphotyrosine residue binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038096">
<property type="term" value="P:Fc-gamma receptor signaling pathway involved in phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0002758">
<property type="term" value="P:innate immune response-activating signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060333">
<property type="term" value="P:interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043299">
<property type="term" value="P:leukocyte degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002522">
<property type="term" value="P:leukocyte migration involved in immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031663">
<property type="term" value="P:lipopolysaccharide-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007498">
<property type="term" value="P:mesoderm development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000251">
<property type="term" value="P:positive regulation of actin cytoskeleton reorganization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030838">
<property type="term" value="P:positive regulation of actin filament polymerization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0008360">
<property type="term" value="P:regulation of cell shape"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050690">
<property type="term" value="P:regulation of defense response to virus by virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051090">
<property type="term" value="P:regulation of DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050727">
<property type="term" value="P:regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050764">
<property type="term" value="P:regulation of phagocytosis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071801">
<property type="term" value="P:regulation of podosome assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045728">
<property type="term" value="P:respiratory burst after phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="CDD" id="cd10363">
<property type="entry name" value="SH2_Src_HCK"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR035851">
<property type="entry name" value="HCK_SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036028">
<property type="entry name" value="SH3-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001452">
<property type="entry name" value="SH3_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00018">
<property type="entry name" value="SH3_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00452">
<property type="entry name" value="SH3DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00326">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50044">
<property type="entry name" value="SSF50044"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50002">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0268">Exocytosis</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0519">Myristate</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0581">Phagocytosis</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0728">SH3 domain</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Tyrosine-protein kinase HCK" id="PRO_0000024433">
<location>
<begin position="2"/>
<end position="526"/>
</location>
</feature>
<feature type="domain" description="SH3" evidence="18">
<location>
<begin position="78"/>
<end position="138"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="17">
<location>
<begin position="144"/>
<end position="241"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="16">
<location>
<begin position="262"/>
<end position="515"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="268"/>
<end position="276"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor">
<location>
<position position="381"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="290"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="36"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="28">
<location>
<position position="51"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12">
<location>
<position position="202"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="15">
<location>
<position position="209"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="22 28">
<location>
<position position="411"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="462"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="21 22 28 35 58">
<location>
<position position="522"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="N-myristoyl glycine" evidence="54">
<location>
<position position="2"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_018858" evidence="62 63 64">
<location>
<begin position="1"/>
<end position="21"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 4." id="VSP_041926" evidence="62 63">
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56029200." id="VAR_041707" evidence="40">
<original>A</original>
<variation>T</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55722810." id="VAR_041708" evidence="31 40">
<original>M</original>
<variation>L</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In an ovarian mucinous carcinoma sample; somatic mutation." id="VAR_041709" evidence="40">
<original>D</original>
<variation>G</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17093828." id="VAR_033836">
<original>P</original>
<variation>Q</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight palmitoylation, cytoplasmic and caveolar localization; in isoform 1;." evidence="29 54">
<original>G</original>
<variation>C</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes palmitoylation and localization at the cell membrane." evidence="29 54">
<original>G</original>
<variation>S</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="mutagenesis site" description="Myristoylation and palmitoylation are abolished, leading to entirely cytoplasmic localization; in isoform 2." evidence="54">
<original>G</original>
<variation>A</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="mutagenesis site" description="Palmitoylation is abolished, some cytoplasmic and no calveolar localization; in isoform 2." evidence="54">
<original>C</original>
<variation>S</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="28">
<original>K</original>
<variation>E</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="22">
<original>E</original>
<variation>A</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="34">
<original>D</original>
<variation>E</variation>
<location>
<position position="381"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced catalytic activity and higher affinity for target peptides." evidence="22">
<original>Y</original>
<variation>A</variation>
<location>
<position position="411"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively activated kinase, leading to cellular transformation." evidence="20 28">
<original>Y</original>
<variation>F</variation>
<location>
<position position="522"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA52643." ref="1" evidence="65">
<original>C</original>
<variation>S</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAF82585." ref="3" evidence="65">
<original>N</original>
<variation>D</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAB15482." ref="3" evidence="65">
<original>W</original>
<variation>R</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAF82585." ref="3" evidence="65">
<original>F</original>
<variation>Y</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAI13855." ref="6" evidence="65">
<original>I</original>
<variation>T</variation>
<location>
<position position="378"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAF82585." ref="3" evidence="65">
<original>N</original>
<variation>S</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="82"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="93"/>
<end position="96"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="99"/>
<end position="102"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="104"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="114"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="127"/>
<end position="129"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="136"/>
<end position="138"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="145"/>
<end position="148"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="151"/>
<end position="159"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="168"/>
<end position="172"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="174"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="180"/>
<end position="188"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="189"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="192"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="204"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="208"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="215"/>
<end position="218"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="219"/>
<end position="228"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="233"/>
<end position="235"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="252"/>
<end position="255"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="259"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="262"/>
<end position="270"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="272"/>
<end position="281"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="282"/>
<end position="284"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="285"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="294"/>
<end position="297"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="299"/>
<end position="309"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="320"/>
<end position="324"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="326"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="330"/>
<end position="333"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="341"/>
<end position="345"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="350"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="355"/>
<end position="374"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="384"/>
<end position="386"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="387"/>
<end position="389"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="395"/>
<end position="397"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="402"/>
<end position="405"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="410"/>
<end position="413"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="416"/>
<end position="419"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="421"/>
<end position="423"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="426"/>
<end position="431"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="436"/>
<end position="451"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="452"/>
<end position="454"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="457"/>
<end position="460"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="463"/>
<end position="471"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="480"/>
<end position="482"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="484"/>
<end position="493"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="498"/>
<end position="500"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="504"/>
<end position="512"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="513"/>
<end position="518"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="521"/>
<end position="523"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1AD5"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QCF"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2HCK"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2HK5"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OI3"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VS2"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VS3"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3VS6"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4U5W"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5H0B"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5H0H"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250"/>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P08103"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00192"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10092522"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10360180"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10644735"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10779760"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10973280"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11278465"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11518702"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11741929"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11896602"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11904303"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12411494"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15010462"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15952790"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15998323"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16216497"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16849330"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16997556"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17141806"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17310994"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17535448"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19114024"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19718658"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19807924"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19903482"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20452982"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20810664"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21338576"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21477083"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21625496"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25469238"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3453117"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7535819"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7791757"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8064233"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8132624"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8995234"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9024658"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9218412"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9406996"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9407116"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3453117"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000305"/>
<sequence length="526" mass="59600" checksum="847E877A0A641725" modified="2007-01-23" version="5">
MGGRSSCEDPGCPRDEERAPRMGCMKSKFLQVGGNTFSKTETSASPHCPVYVPDPTSTIK
PGPNSHNSNTPGIREAGSEDIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSL
ATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSY
SLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVP
CMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE
AFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID
FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP
IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE
NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYQQQP
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>